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SUPPLEMENTARY NOTES
ABSTRACT
This project seeks to add to research knowledge that impacts racial disparities in prostate cancer by examining how prostate cancer experience of fathers influence the prostate health preventive patterns of their adult sons. The study will combine qualitative and quantitative research techniques to assess the knowledge, attitudes, preventive health practices, and prostate cancer related informed decision making of adult sons of prostate cancer survivors and how these factors relate to the diagnostic pathways, treatment experience, and quality of life of their fathers. 
Rationale:
The burden associated with prostate cancer fall disproportionately on African American men. The prostate cancer incidence rate among African American (AA) men is 55% greater than that of Caucasian (CA) men and, according to the National Cancer Institute (NCI) state cancer profiles, the mortality rate is almost three times that of CA men (73.9 per 100,000 AA / 25.6 per 100,000 C). Genetic and dietary factors have been identified in explaining a portion of the excess burden experienced by AA men, yet we have been unable to identify risk factors that are both of substantial magnitude and amenable to preventive intervention. AA men are less likely to be enrolled in clinical trials and there are indications that supportive services may not be as readily available to them. While AAs have a substantially worse profile with regard to prostate cancer, differential use of preventive health behaviors such as prostate cancer screening may attenuate the racial disparities in prostate cancer outcomes, yet, research examining the factors associated with such behaviors is underdeveloped. Family history is one of few predictors of elevated prostate cancer risk. Accordingly, the proposed study will focus on the sons of men with prostate cancer, and will examine the roles of informed decision-making, knowledge on utilization of prostate cancer screening procedures, individual socioeconomic characteristics, characteristics of the father-son relationship, and characteristics of the father's prostate cancer experience as they may be associated with sons' consequent use of prostate cancer preventive/early detection behaviors.
The study will combine qualitative and quantitative research techniques to assess the knowledge, attitudes, and preventive practices of adult sons ("sons") of men with prostate cancer ("fathers"). It will be conducted in parallel with an examination of men with prostate cancer ("The Fathers Study"), the goals of which are (1) to investigate the effects of race, economic status, and psychosocial factors on the quality of life of men diagnosed with prostate cancer; (2) to investigate psychosocial factors that influence help seeking behavior among men who were diagnosed with prostate Annual Report August, 2013 5 cancer; and (3) to examine the effects of informed decision-making and knowledge on prostate cancer treatment decisions-making. Correspondingly, the participants in this study ("The Sons Study") will be the adult sons of men with prostate cancer. Equal numbers of African American and white males with prostate cancer will be identified for The Fathers Study. These men, in turn, will be asked to identify their sons, who will be contacted for participation in this, The Sons Study. The study consists of a telephone interview.
For the parent study ("The Father's Study"), Dr. Her appointment as PI will enhance the project, and ensure the project goals and objectives are met. As with The Fathers Study, the Sons survey will be conducted at CSR which is now located at Johns Hopkins Bloomberg School of Public Health (JHBSPH) located in Raleigh, NC. The Sons Study dataset used for analyses will be housed at the JHBSPH located at 624 N. Broadway, Hampton House Suite 441, Baltimore, MD site under the supervision of Dr. LaVeist, which is also the location of the parent study dataset.
The purpose of the study is to identify factors that influence prostate cancer prevention/early detection behaviors among sons of men with prostate cancer. We will prospectively recruit 315 white and 315 African American sons of men who enter the North Carolina Central Cancer Registry (NCCCR) by obtaining contact information for the sons from the fathers that participate in the Fathers Study. To date, we have been able to recruit 891 fathers to participate in the Fathers Study; therefore, the 630 sons will be recruited from this pool.
We will employ appropriate statistical procedures to analyze data obtained from survey responses and address the study's major hypotheses. Descriptive statistics including means and percentages will be examined. Regular use of prostate cancer screening will be assessed using logistic regression and generalized estimating equations to assess trends over time. Model selection procedures will be employed to determine optimal set of predictors for our outcome. All tests will be two-sided with and significance will be determined by a p-value less than 0.05. All analyses will be conducted using SAS version 9.1 (SAS Institute, Cary, NC). Complete a sub-contract with Johns Hopkins University.
BODY:
Secure IRB approval at Meharry Medical College and at Johns Hopkins University.
Interview, hire and train student research interviewers (Ms. Carol Burt) to recruit, consent, and conduct the study interviews.
Deliverables: Sub-Contract to JHU IRB Approvals from both institutions Trained interviewers.
Task 2: Data Collection (Month 5 -8)
Recruiting and interviewing study participants.
Complete data entry of all interview information collected. (Ms. Carol Burt).
Deliverables: Recruitment brochure Complete data collection program & Complete data file of study participants.
Task 3: Report and Presentation of Program Outcome (Month 9 -12)
Data analysis, result interpretations, and manuscript development. provides authorization that the research may proceed. Written approval to begin research will be issued from the USAMRMC ORP, under separate notification to the recipient. Written approval from the USAMRMC ORP is also required for any subrecipient that will use funds from this award to conduct research involving human subjects.
Research involving human subjects shall be conducted in accordance with the protocol submitted to and approved by the USAMRMC ORP. Complete study records shall be maintained for each human research study and shall be made available for review by representatives of the USAMRMC. Research records shall be stored in a confidential manner so as to protect the confidentiality of subject information 
KEY RESEARCH ACCOMPLISHMENTS: [Bulleted list of key research accomplishments emanating from this research.]
This program did not meet any of its research goals because of the sudden departure of the original PI, Daniel Howard, Ph.D. However, before he left the sub-contract with JHU was established.
IRB at Meharry was obtained and so was IRB approval at JHU to begin developing the study protocol.
The program research administrator, Mr. Jarod Lockhart, prepared IRB continuing review and worked with Dr. Flora Ukoli (the new PI) and Mr. G. Ballard, Director of Grants Management, to prepare a Status Report as shown below. Mr. Lockhart has since left Meharry Medical College.
REPORTABLE OUTCOMES: [Provide a list of reportable outcomes that have resulted from this research to include:]
Developed a computer program for data collection and storage. (Consultant)
CHALLENGES:
Resignation of Key personnel
The resignation of Daniel Howard (PI) from Meharry Medical College was a major setback for this study. This has been overcome by the appointment of a new PI, Flora A. M. Ukoli, MD, MPH
Report Preparation
A status report was submitted by Mr. J. Lockhart. ters and final reports.
CONCLUSIONS: [Summarize the results to include the Importance and/or implications of the completed research and when necessary, recommend changes on future work to better address the problem. A "so what section" which evaluates the knowledge as a scientific or medical product shall also be included in the conclusion of the report. ]
It is highly encouraging that the Department of Defense approved a non-cost extension and allowed the study to continue in view of the administrative challenges. For all men the risk of prostate cancer increases with age, especially after age 50. However, prostate cancer may occur earlier and be more aggressive among African-American men.
Other possible risk factors include obesity, lifestyle and environmental exposure.
T h e M e h a r ry-J o h n s H o p k i n s C e n t e r f o r P r o s t a t e C a n c e r R e s e a r c h We want to better understand how personal experience and risk perception impact lifestyle choices and screening behaviors of adult men. We believe that, by working together, we can find ways to reduce the impact of prostate cancer in men and their families for current and future generations.
This study is not a clinical trial. It is a survey asking for men's responses to questions. We will not ask participants to take medicine or drugs, give blood or other such medical specimens and, we will not give any kind of medical treatment. 
